Top Articles

In 2016, the EAN president Günther Deuschl and ECTRIMS (European Committee for Treatment and Research in MS) president Xavier Montalban have decided to join the forces of the two societies, and prepare a common guideline for the treatment of multiple sclerosis (MS). In view of the recent increase of medications approved for relapsing- and progressive MS, evidence-based guidance is needed to ensure standardized treatment of MS patients throughout Europe.

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

David B Vodušek (DBV): In light of your long-standing experience in the world of neurology world-wide, what would your “diagnosis” be concerning its “state of art”? William Carroll (WC): What a good question to begin with. I would say my “diagnosis” is healthy and its prognosis is one of cautious optimism mixed with exciting opportunities and challenges.

It is a great pleasure to introduce the recipients of the Research Fellowship 2018 (in alphabetical order):

Outcome of the elections of the new Executive During the November 22nd, Board meeting the elections for the EBC new Executive took place. The new Executive is composed as follows: • President Prof. Monica di Luca (FENS)
• 1st Vice… Continue Reading

Situated at the north-eastern end of the Mediterranean basin, Cyprus is the third largest island in the region, with an area of 9,251 square kilometers (3,572 square miles). Cyprus is a small island with a long history and a rich culture that spans 10,000 years, making it one of the oldest civilizations in the Mediterranean area. Situated at the crossroads of three continents - Europe, Asia and Africa - the island’s unique geographic position has played an important part in its turbulent past since antiquity. The island was divided in 1974 following the Turkish invasion.

David B. Vodušek (DBV): The Scientific Panel for Health – SPH is an official and unique panel of the EC within H2020. Can you introduce the SPH to the readers of EAN and explain its tasks? Karin Sipido (KS): The European Commission’s Scientific Panel for Health is a science-led expert group based on the provisions of the Horizon2020 Specific Programme.

Registration for the 4th EAN Congress in Lisbon, Portugal, 16-19 June 2018, is now possible! If you are a member of EAN, you can save up to 200€ – benefit now from our reduced membership fees. Don’t forget to sign… Continue Reading

A new guideline on cerebral venous thrombosis (CVT) diagnosis and treatment issued by the European Stroke Organization (ESO) and endorsed by the European Academy of Neurology (EAN) was recently published in ESO (long version) and EAN (abbreviated version) official journals [1, 2].

The 9th exam of the European Board of Neurology took place in Amsterdam on June 23rd last, one day before the start of the 3rd EAN congress.

Title of the project: “Delineating the molecular mechanisms of mitochondrial DNA disease: clinical and pathological studies”

We congratulate the winners of the Investigator Awards to their presentation during the
3rd EAN Congress in Amsterdam 2017! The Prize consists of an Award certificate and free registration to the Lisbon Congress.   All winners’ presentations were filmed –… Continue Reading

The special session of the Residents and Research Fellow Section (RRFS) took place on Sunday 25.06.2017 during the EAN congress 2017 in Amsterdam. This year the special session was held in a novel format with the aim to create a more informal environment between juniors and senior researchers and clinicians.

Symposium 6: Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) as a model of interaction between cognition, behaviour and motor impairment Chairpersons: 
Albert C. Ludolph, Ulm, Germany
Yolande A.L. Pijnenburg, Ouderkerk aan de Amstel, The Netherlands The neuropathology of ALS… Continue Reading

eter Van den Bergh (PVdB): Peripheral neuropathies are common neurological disorders. In the annual EAN congresses, they are an important topic which the Scientific Panel Neuropathies strives to integrate in the scientific and in the educational Program. I would like to introduce the Peripheral Nerve Society (PNS) of which you are the president to the EANpages readership. Can you please explain what the PNS stands for and what its objectives and aims are to the readers of the EANpages? Mary Reilly (MR): The Peripheral Nerve Society (PNS) is an international organisation of physicians and scientists working together to develop and provide the best treatments for people who have peripheral nerve diseases.